Lenalidomide for the richmond VAMC for patient care
Active Awarded Last action
- Contract number
- 36C24626N0420
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $4,060,519
Award facts
- Contract value 100% obligated
- $4,060,518.84 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 6 (VISN 6) awarded a delivery order valued at $4.06 million to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide to the Richmond VA Medical Center. This firm-fixed-price delivery order, issued on January 15, 2026, with an ultimate completion date of January 14, 2027, supports the VA's oncology and hematologic malignancy treatment protocols. The contract contains no set-aside designation, allowing Exelan to compete on an unrestricted, fully open basis. Exelan Pharmaceuticals, headquartered in Boca Raton, Florida, serves as a critical pharmaceutical supplier to the VA and other federal healthcare systems, specializing in the production, distribution, and repackaging of generic and branded pharmaceutical products into patient-ready prescriptions.
This delivery order is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and represents a continuation of Exelan's established role as a long-term strategic supplier to the VA's pharmaceutical procurement requirements. Exelan maintains an extensive portfolio of Indefinite Delivery Contracts with the VA National Acquisition Center, including a Blanket Purchase Agreement with VISN 22 for Lenalidomide products valued at $21.17 million, along with numerous other single-award indefinite delivery contracts for critical medications with ceiling values ranging from $12.8 million to $88.2 million. The company performs substantially all work at its Boca Raton facility and operates as a prime contractor without identified major subcontractors, supporting the VA's mission to deliver specialized pharmaceutical treatments across its healthcare system.
Quick answers
Who was awarded contract 36C24626N0420?
36C24626N0420 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on January 15, 2026.
How much is contract 36C24626N0420 worth?
The government has obligated $4,060,519 on 36C24626N0420.
Is contract 36C24626N0420 an order under another contract?
Yes. 36C24626N0420 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626N0420 competed?
The extent of competition for 36C24626N0420 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award